SaskPharm: a proposal for provincial drug production.
作者信息
Meili Ryan
机构信息
College of Medicine, University of Saskatchewan, Saskatoon, Sask.
出版信息
CMAJ. 2011 Jul 12;183(10):1224. doi: 10.1503/cmaj.101814. Epub 2011 May 24.
Abstract
摘要
相似文献
1
SaskPharm: a proposal for provincial drug production.萨斯喀彻温省制药公司：省级药品生产提案。
CMAJ. 2011 Jul 12;183(10):1224. doi: 10.1503/cmaj.101814. Epub 2011 May 24.
2
Competition watchdog finds new target: overpriced generics.
BMJ. 2016 Dec 14;355:i6712. doi: 10.1136/bmj.i6712.
3
Angst about exclusivity: The potential cost of incentivizing makers of generic drugs.对排他性的担忧：激励仿制药制造商的潜在成本。
Nat Med. 2017 Oct 6;23(10):1114-1116. doi: 10.1038/nm1017-1114.
4
5
Brand-name versus generic.品牌药与非专利药。
Health Aff (Millwood). 2007 Jul-Aug;26(4):1198-9; author reply 1199. doi: 10.1377/hlthaff.26.4.1198-a.
6
Expensive Medicine: Drug prices are increasingly hard to swallow. Effective remedies prove elusive.昂贵的药物：药品价格越来越让人难以承受。有效的治疗方法却难以寻觅。
Minn Med. 2017 May;100(3):10-17.
7
The new drug war.新药之战
US News World Rep. 2002 Dec 2;133(21):41.
8
Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry.制药行业中的反垄断、市场独占权与透明度
JAMA. 2018 Jun 12;319(22):2271-2272. doi: 10.1001/jama.2018.3478.
9
10
Selling Patents to Indian Tribes to Delay the Market Entry of Generic Drugs.向印第安部落出售专利以延缓仿制药进入市场。
JAMA Intern Med. 2018 Feb 1;178(2):179-180. doi: 10.1001/jamainternmed.2017.7463.
Zotero 插件